|
05 Nov 2019
|
Mangalam Drugs
|
ICICI Securities Limited
|
79.32
|
|
35.85
(121.26%)
|
|
Sell
|
|
|
Mangalam Drugs & Organics (Mangalam) is one of the largest and most preferred API suppliers for anti-malarial drug manufacturing companies in India and abroad. It is one of the five companies globally to qualify under the Bill Clinton Foundation for supply of anti-malarial drugs. The company's APIs are largely supplied to companies, which participate in WHO tenders and are funded by various global agencies like Clinton Foundation, Gates...
|
|
19 Apr 2017
|
Mangalam Drugs
|
ICICI Securities Limited
|
79.32
|
225.00
|
170.10
(-53.37%)
|
Target met |
Buy
|
|
|
|